Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-14

Clinical Trial Update: Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results comparing Symbicort as-needed, Bricanyl as-needed, or Pulmicort once daily plus Bricanyl as-needed in patients with exercise-induced asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bricanyl (terbutaline)
  • Pulmicort (budesonide)
  • Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Exercise Induced Asthma | Phase 2 | Status: COMPLETED | Results posted: 2012-08-14